Quaker Chemical swings to Q2 2026 profit of USD 26.8 million, or USD 1.55 per diluted share, on net sales up 10% to USD 532.6 million.
Adjusted EBITDA rose 13% to USD 85.2 million, reflecting higher net sales, partly offset by higher SG&A expense.
Sales volumes climbed 7% year over year, driven by new business wins across all segments; foreign currency translation added 2% to net sales.
Capital returns and outlook
Quarterly dividend increased about 4.3%; Q2 share repurchases totaled USD 24.2 million, alongside a new USD 250 million buyback program.
Management flagged stable demand entering Q3, with flat to slightly positive end markets expected for the rest of 2026 amid Strait of Hormuz conflict-related volatility.